Ironwood Pharmaceuticals to acquire Swiss biotech VectivBio in deal valued at about 1 billion
VECTDelisted Stock | USD 16.85 0.00 0.00% |
Slightly above 56% of VectivBio Holding's investor base is looking to short. The analysis of current outlook of investing in VectivBio Holding AG suggests that many traders are alarmed regarding VectivBio Holding's prospects. VectivBio Holding's investing sentiment can be driven by a variety of factors including economic data, VectivBio Holding's earnings reports, geopolitical events, and overall market trends.
VectivBio |
Ironwood Pharmaceuticals Inc. said Monday it has agreed to acquire Swiss biotech VectivBio Holding AG for 17 a share in cash, or a total of about 1...
Read at marketwatch.com
VectivBio Holding Fundamental Analysis
We analyze VectivBio Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VectivBio Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VectivBio Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
VectivBio Holding is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
VectivBio Holding Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VectivBio Holding stock to make a market-neutral strategy. Peer analysis of VectivBio Holding could also be used in its relative valuation, which is a method of valuing VectivBio Holding by comparing valuation metrics with similar companies.
Peers
VectivBio Holding Related Equities
CNSP | Cns Pharmaceuticals | 10.00 | ||||
ZVSA | ZyVersa Therapeutics | 10.00 | ||||
HEPA | Hepion Pharmaceuticals | 7.69 | ||||
ZURA | Zura Bio | 0.80 | ||||
ELEV | Elevation Oncology | 5.97 | ||||
OCEA | Ocean Biomedical | 7.94 | ||||
IMMX | Immix Biopharma | 8.30 | ||||
ENVB | Enveric Biosciences | 10.81 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in VectivBio Stock
If you are still planning to invest in VectivBio Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VectivBio Holding's history and understand the potential risks before investing.
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |